Global Capecitabine Market Research Report 2011-2023
- HEY2147166
- 77 Pages
- September 2017
- Healthcare
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
The global Capecitabine market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
500 mg
150 mg
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Teva
Roche
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Breast Cancer
Colorectal cancer
Stomach Cancer
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 500 mg
1.2.1.2 150 mg
1.2.2 by Application
1.2.2.1 Breast Cancer
1.2.2.2 Colorectal cancer
1.2.2.3 Stomach Cancer
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 500 mg Market, 2011-2016
4.1.2 150 mg Market, 2011-2016
4.2 Market Forecast
4.2.1 500 mg Market Forecast, 2017-2022
4.2.2 150 mg Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Breast Cancer Market, 2011-2016
5.1.2 Colorectal cancer Market, 2011-2016
5.1.3 Stomach Cancer Market, 2011-2016
5.2 Market Forecast
5.2.1 Breast Cancer Market Forecast, 2017-2022
5.2.2 Colorectal cancer Market Forecast, 2017-2022
5.2.3 Stomach Cancer Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Teva
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Roche
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Mylan
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Hikma
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Hengrui Medicine
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Cipla
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 Reliance Group
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Hetero
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
9 Conclusion
List Of Tables
Table Product Specifications of Capecitabine
Table Products Segment of Capecitabine
Table 500 mg Overview
Table 150 mg Overview
Table Global Capecitabine Market by Type, 2011-2022 (USD Million)
Table Application Segment of Capecitabine
Table Breast Cancer Overview
Table Colorectal cancer Overview
Table Stomach Cancer Overview
Table Global Capecitabine Market by Application, 2011-2022 (USD Million)
Table Global Capecitabine Market by Region, 2011-2022 (USD Million)
Table Cost of Capecitabine
Table Market Dynamics
Table Policy of Capecitabine
Table GDP of Major Countries
Table 500 mg CAGR by Revenue and Volume, 2011-2016
Table 150 mg CAGR by Revenue and Volume, 2011-2016
Table 500 mg CAGR by Revenue and Volume, 2012-2022
Table 150 mg CAGR by Revenue and Volume, 2012-2022
Table Breast Cancer CAGR by Revenue and Volume, 2011-2016
Table Colorectal cancer CAGR by Revenue and Volume, 2011-2016
Table Stomach Cancer CAGR by Revenue and Volume, 2011-2016
List Of Figures
Figure Capecitabine Picture
Figure Industry Chain Structure of Capecitabine
Figure SWOT of Capecitabine
Figure 500 mg Market Size and Growth, 2011-2016 (USD Million)
Figure 500 mg Market Size and Growth, 2011-2016 (in Volume)
Figure 150 mg Market Size and Growth, 2011-2016 (USD Million)
Figure 150 mg Market Size and Growth, 2011-2016 (in Volume)
Figure 500 mg Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure 500 mg Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure 150 mg Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure 150 mg Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Breast Cancer Market Size and Growth, 2011-2016 (USD Million)
Figure Breast Cancer Market Size and Growth, 2011-2016 (in Volume)
Figure Colorectal cancer Market Size and Growth, 2011-2016 (USD Million)
Figure Colorectal cancer Market Size and Growth, 2011-2016 (in Volume)
Figure Stomach Cancer Market Size and Growth, 2011-2016 (USD Million)
Figure Stomach Cancer Market Size and Growth, 2011-2016 (in Volume)
Figure Breast Cancer Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Breast Cancer Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Colorectal cancer Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Colorectal cancer Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Stomach Cancer Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Stomach Cancer Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Capecitabine Market Concentration by Region
Figure Marketing Channels Overview
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
